prescriptions

Pharma bribery corrupts health care, puts patients at risk, new review warns

Kickbacks, sham studies and regulatory payoffs distort prescribing and drug approvals

|
Print Email Share Tweet LinkedIn WhatsApp Reddit Telegram
Pills and 100 dollar bills

Sham clinical studies, slush funds, luxury gifts, and shell companies: A new review shows how pharma firms allegedly bribed their way to drug approvals and sales.

Drug and medical device companies target next generation of physicians, put patients at risk, experts say

|
Print Email Share Tweet LinkedIn WhatsApp Reddit Telegram

Drug and medical device companies are courting medical students and early-career clinicians with promotional activities that endanger patient health, experts say.